- Home
- ISRL vs SRTS Comparison
ISRL vs SRTS Comparison
Compare ISRL & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRL
- SRTS
- Stock Information
- Founded
- ISRL 2021
- SRTS 2010
- Country
- ISRL United States
- SRTS United States
- Employees
- ISRL N/A
- SRTS N/A
- Industry
- ISRL Blank Checks
- SRTS Medical/Dental Instruments
- Sector
- ISRL Finance
- SRTS Health Care
- Exchange
- ISRL Nasdaq
- SRTS Nasdaq
- Market Cap
- ISRL 79.7M
- SRTS 75.5M
- IPO Year
- ISRL 2023
- SRTS 2016
- Fundamental
- Price
- ISRL $12.63
- SRTS $3.15
- Analyst Decision
- ISRL
- SRTS Strong Buy
- Analyst Count
- ISRL 0
- SRTS 3
- Target Price
- ISRL N/A
- SRTS $8.00
- AVG Volume (30 Days)
- ISRL 2.1K
- SRTS 84.3K
- Earning Date
- ISRL 01-01-0001
- SRTS 11-13-2025
- Dividend Yield
- ISRL N/A
- SRTS N/A
- EPS Growth
- ISRL N/A
- SRTS N/A
- EPS
- ISRL 0.14
- SRTS N/A
- Revenue
- ISRL N/A
- SRTS $37,564,000.00
- Revenue This Year
- ISRL N/A
- SRTS N/A
- Revenue Next Year
- ISRL N/A
- SRTS $33.38
- P/E Ratio
- ISRL $93.55
- SRTS N/A
- Revenue Growth
- ISRL N/A
- SRTS 3.29
- 52 Week Low
- ISRL $11.14
- SRTS $3.03
- 52 Week High
- ISRL $14.00
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- ISRL 52.16
- SRTS 35.90
- Support Level
- ISRL $11.99
- SRTS $3.16
- Resistance Level
- ISRL $12.70
- SRTS $3.29
- Average True Range (ATR)
- ISRL 0.13
- SRTS 0.13
- MACD
- ISRL 0.01
- SRTS 0.05
- Stochastic Oscillator
- ISRL 90.14
- SRTS 10.81
About ISRL Israel Acquisitions Corp
Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.